Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qigui Yishen Prescription (First Affiliated Hospital of Soochow University)
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Soochow University
- Administration
- Oral
01
Overview
Qigui Yishen Prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by the First Affiliated Hospital of Soochow University. It is primarily investigated for its potential to mitigate and delay the progression of acute and chronic kidney diseases, particularly those induced by platinum-based chemotherapy agents such as cisplatin. The prescription typically contains *Astragalus membranaceus* (Huangqi) and *Angelica sinensis* (Danggui), which are traditionally used in TCM to tonify Qi and enrich blood while specifically targeting kidney health. In clinical settings, it is used in combination with Western medical protocols to provide a synergistic effect in preserving renal function, reducing nephrotoxicity, and managing chronic renal failure.
- Other names
- Qigui Yishen DecoctionQigui Yishen FormulaQi Gui Yi Shen Fang
02
Targets
COL1A1 (Collagen type I alpha 1 chain)PAI-1 (Plasminogen activator inhibitor type 1)THBD (Thrombomodulin)TGFB1 (Transforming growth factor Beta-1 proprotein)
Beyond the preview
Go deeper on Qigui Yishen Prescription (First Affiliated Hospital of Soochow University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qigui Yishen Prescription (First Affiliated Hospital of Soochow University).